AustralianSuper’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$160M Buy
409,438
+183,488
+81% +$77.6M 0.69% 37
2026
Q1
$107M Buy
225,950
+83,578
+59% +$42.1M 0.56% 49
2025
Q4
$66.5M Buy
142,372
+95,181
+202% +$44.2M 0.31% 69
2025
Q3
$20.1M Buy
47,191
+29,341
+164% +$11.4M 0.1% 142
2025
Q2
$6.84M Hold
17,850
0.03% 196
2025
Q1
$6.17M Hold
17,850
0.03% 164
2024
Q4
$5.36M Sell
17,850
-17,643
-50% -$6.17M 0.03% 168
2024
Q3
$14.4M Buy
35,493
+19,247
+118% +$7.05M 0.07% 93
2024
Q2
$5.22M Buy
16,246
+1,165
+8% +$379K 0.03% 143
2024
Q1
$4.98M Hold
15,081
0.03% 150
2023
Q4
$4.08M Sell
15,081
-5,617
-27% -$1.39M 0.02% 180
2023
Q3
$5.09M Buy
20,698
+637
+3% +$174K 0.03% 148
2023
Q2
$6.09M Buy
+20,061
New +$5.58M 0.04% 158
2020
Q3
Sell
-173,239
Closed -$16.8M 165
2020
Q2
$16.8M Buy
+173,239
New +$18M 0.16% 73
2017
Q4
Sell
-306,700
Closed -$24.4M 48
2017
Q3
$24.4M Buy
+306,700
New +$24.7M 1.1% 27

Other funds holding HCA

AustralianSuper's HCA Position: Q2 2026 in Review

AustralianSuper increased its HCA Healthcare (HCA) stake by 81% in Q2 2026, buying an estimated $77.6M and bringing the position to 409,438 shares worth $160M. The position accounts for 0.69% of the portfolio, ranked #37.

AustralianSuper first reported a position in HCA in Q3 2017 and has held it in 15 quarters since. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • AustralianSuper held 409,438 shares of HCA Healthcare worth $160M as of Q2 2026.
  • AustralianSuper bought 183,488 HCA Healthcare shares in Q2 2026, an estimated $77.6M.
  • HCA Healthcare made up 0.69% of AustralianSuper's portfolio in Q2 2026, its #37 holding.
  • AustralianSuper first reported a position in HCA Healthcare in Q3 2017 and has held it in 15 quarters since.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on AustralianSuper's 13F filing for Q2 2026, filed 12 Aug 2026.